- Home
- SLGL vs CCM Comparison
SLGL vs CCM Comparison
Compare SLGL & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGL
- CCM
- Stock Information
- Founded
- SLGL 1997
- CCM 1997
- Country
- SLGL Israel
- CCM China
- Employees
- SLGL N/A
- CCM N/A
- Industry
- SLGL Biotechnology: Pharmaceutical Preparations
- CCM Medical/Nursing Services
- Sector
- SLGL Health Care
- CCM Health Care
- Exchange
- SLGL Nasdaq
- CCM Nasdaq
- Market Cap
- SLGL 18.3M
- CCM 18.2M
- IPO Year
- SLGL 2018
- CCM 2009
- Fundamental
- Price
- SLGL $0.52
- CCM $4.44
- Analyst Decision
- SLGL Strong Buy
- CCM
- Analyst Count
- SLGL 2
- CCM 0
- Target Price
- SLGL $5.00
- CCM N/A
- AVG Volume (30 Days)
- SLGL 68.5K
- CCM 6.6K
- Earning Date
- SLGL 11-15-2024
- CCM 11-29-2024
- Dividend Yield
- SLGL N/A
- CCM N/A
- EPS Growth
- SLGL N/A
- CCM N/A
- EPS
- SLGL N/A
- CCM N/A
- Revenue
- SLGL $11,707,000.00
- CCM $64,910,622.00
- Revenue This Year
- SLGL $457.85
- CCM N/A
- Revenue Next Year
- SLGL N/A
- CCM N/A
- P/E Ratio
- SLGL N/A
- CCM N/A
- Revenue Growth
- SLGL 869.93
- CCM N/A
- 52 Week Low
- SLGL $0.33
- CCM $3.80
- 52 Week High
- SLGL $1.58
- CCM $26.70
- Technical
- Relative Strength Index (RSI)
- SLGL 37.57
- CCM 29.19
- Support Level
- SLGL $0.40
- CCM $4.20
- Resistance Level
- SLGL $0.57
- CCM $5.50
- Average True Range (ATR)
- SLGL 0.06
- CCM 0.78
- MACD
- SLGL -0.01
- CCM -0.21
- Stochastic Oscillator
- SLGL 36.50
- CCM 5.13
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.